- About Us
- Research & Pipeline
- Investor Centre
- Media Centre
Welcome to Kazia Therapeutics
Novel Australian drug GDC-0084 for glioblastoma brain cancer starts Phase II clinical trial in US read more
Mr Ian Phillips MNZM
Interim Chairman from July 2015 – February 2016 and Non-Executive Director from March 2016 – to June 2017. Ian made a memorable contribution to the Company at a pivotal time in its history. We will remember him with great fondness.
Ian passed away on 1 October 2018 in New York.